# Phase I Study of PollenVax in Patients With Mugwort Pollen-Induced Allergic Rhinitis

> **NCT07317960** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Kazakh National Agrarian University** · enrollment: 30 (actual)

## Conditions studied

- Allergic Rhinitis Due to Artemisia Pollen

## Interventions

- **BIOLOGICAL:** PollenVax
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07317960
- **Lead sponsor:** Kazakh National Agrarian University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-11-22
- **Primary completion:** 2026-01-14
- **Final completion:** 2026-01-19
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07317960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07317960, "Phase I Study of PollenVax in Patients With Mugwort Pollen-Induced Allergic Rhinitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07317960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*